🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Deeply pleased and honored to receive the recognition of best oral presentation of the 43rd Italian Society of Interventional Cardiology congress Sici GISE Deep thanks to my mentor and PI of the study Domenico D'Amario and all RIALTO members. #interventionalcardiology #myocardialbridge

Are we healed from the "Yentl syndrome" with regard to antithrombotic therapy? Have a look to our review just published in Frontiers. Domenico D'Amario Outside of the Box 🇭🇷🇪🇺 Mattia Galli Giuseppe Ciliberti Attilio Restivo frontiersin.org/articles/10.33…

frontiersin.org/articles/10.33… Renzo Laborante Attilio Restivo Domenico D'Amario

ECPELLA versus #ECMO in #CardiogenicShock – do the potential benefits of this unloading strategy outweigh the increased complications? academic.oup.com/ehjqcco/advanc… #EHJQCCO #CathLab Prof Chris P Gale Diogo Santos Ferreira

Take home message for 2023: be careful of adenosine! Renzo Laborante Emiliano Bianchini Attilio Restivo Mattia Galli Andrea Zito Giuseppe Princi Daniele Rodolico Domenico D'Amario EHJ Editor-in-Chief

Direction is much more important than speed.

In this observational study, Domenico D'Amario Daniele Rodolico et al highlight how many patients with new HFrEF do not receive the 4 pillars of GDMT. Their data suggests those on more classes of GDMT at hospital discharge may have better outcomes. #AHAJournals ahajrnls.org/3Ovj3Sd

“An expert is a person who has made all the mistakes that can be made in a very narrow field.” – Niels Bohr

sciencedirect.com/science/articl…

sciencedirect.com/science/articl… Domenico D'Amario Outside of the Box 🇭🇷🇪🇺 Emiliano Bianchini High-dose statins in preventing mvo: the devil lies in details

Impact of Ethnicity on Antiplatelet Treatment Regimens for Bleeding Reduction in Acute Coronary Syndromes: A Systematic Review and Pre-specified Subgroup Meta-analysis, by Galli et al academic.oup.com/ehjcvp/advance… Mattia Galli Davide Capodanno Dr Roxana Mehran Domenico D'Amario

Ethnicity should be taken into account when interpreting results from trials testing different antiplatelet regimens for bleeding reduction in ACS. bit.ly/47ISNLt European Society of Cardiology Journals Davide Capodanno SABOURETCardiologist Giuseppe Biondi-Zoccai Felice Gragnano Stefan Agewall

Gaetano Rizzo poignantly addresses the issues of myocardial bridging and its functional assessment at the Italian Society of Cardiology Congress sicardiologia.it SIC Società Italiana di Cardiologia

There is no authority who decides what is a good idea.

Comorbidities and CRT: Do we talk the talk or should we walk the walk? 📌#CRT has potential to improve HF outcomes but is underutilized, especially in patients with comorbidities. 📌Trials show CRT's benefits, yet real-world evidence suggests gaps in addressing diverse patient

🧬 Comparative effects of different #antiplatelet strategies in carriers of #CYP2C19 loss-of-function alleles: a new network meta-analysis in #EHJPharmacotherapy bit.ly/3yh7ybq EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli Giuseppe Biondi-Zoccai Giovanni Occhipinti #CardioTwitter

"A good teacher does not teach facts, he or she teaches enthusiasm, open-mindedness and values." -- Gian-Carlo Rota

Safety and efficacy of early initiation of #SGLT2i after #ACS. An updated meta-analysis just published in #EHJPharmacotherapy bit.ly/3Z5K1G3 EHJ-CVP Editor-in-Chief Felice Gragnano Renzo Laborante Domenico D'Amario Gianluigi Savarese Cardiologia Novara

Knowledge grows when you ask stupid questions. Stupidity grows when you don't ask anything.

Study design and rationale of the AZIMUTH trial: a smartphone, app-based, #eHealth integrated model of care for #HeartFailure patients ow.ly/OC1f50VLY08 #EHJDigital #mHealth Nico Bruining EiC EHJ Digital Health rafavidalperez Folkert Asselbergs Ruben Casado Arroyo HFAPresident